ALB and cardiomyopathy: Compared with the marked BNP improvement group, the BNP worsening and no-marked BNP change groups had lower serum albumin, hemoglobin and eGFR and had a lower prevalence of cardiomyopathy etiology and β-blocker use and a higher proportion of diuretics use (Table 1).